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Popular scientific summary
•  Qualified systematic review (SRs) (i.e. high-quality SRs) are the preferred method for evaluating 
causal effects of nutrients or food groups on health outcomes in NNR2022.
•  Most SRs published in scientific journals do not fulfill all criteria of a qualified SR.
• This article discusses the structure and rationale of qualified SRs in NNR2022.
Abstract
Background: Qualified systematic reviews (SRs) will form the main basis for evaluating causal effects of nu-
trients or food groups on health outcomes in the sixth edition of Nordic Nutrition Recommendations to be 
published in 2022 (NNR2022).
Objective: To describe rationale and structure of SRs used in NNR2022.
Design: The SR methodologies of the previous edition of NNR were used as a starting point. Methodolo-
gies of recent SRs commissioned by leading national food and health authorities or international food and 
health organizations were examined and scrutinized. Methodologies for developing SRs were agreed by the 
NNR2022 Committee in a consensus-driven process.
Results: Qualified SRs will be developed by a cross-disciplinary group of experts and reported according to 
the requirements of the EQUATOR network. A number of additional requirements must also be fulfilled, 
including 1) a clearly stated set of objectives and research questions with pre-defined eligibility criteria for the 
studies, 2) an explicit, reproducible methodology, 3) a systematic search that attempts to identify all studies 
that would meet the eligibility criteria, 4) an assessment of the validity of the findings of the included studies 
through an assessment of ‘risk of bias’ of the studies, 5) a systematic presentation and synthesis of the charac-
teristics and findings of the included studies, and 6) a grading of the overall evidence. The complete definition 
and requirements of a qualified SR are described.
Discussion: Most SRs published in scientific journals do not fulfill all criteria of the qualified SRs in the 
NNR2022 project. This article discusses the structure and rationale for requirements of qualified SRs in 
NNR2022. National food and health authorities have only recently begun to use qualified SRs as a basis for 
nutrition recommendations.
Conclusion: Qualified SRs will be used to inform dietary reference values (DRVs) and food-based dietary 
guidelines (FBDGs) in the NNR2022 project.
Keywords: dietary reference values; food-based dietary guidelines; systematic reviews; national food and health authorities; 
Nordic countries; Baltics; evidence-based nutrition; nutrient recommendations; causal relationships
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This article is the second of a three-part series for the  Nordic Nutrition Recommendations 2022 (NNR2022):
1. Principles and methodologies (1),
2. Structure and rationale of qualified systematic reviews 
(this  article), and 
3. Handbook for qualified systematic reviews (2).
Together, these documents constitute a comprehensive 
and precise framework for how we plan to update NNR. 
The first paper (1) describes the organization, principles, 
methods, and the systematic approach used for the sixth 
edition of the NNR (NNR2022). The present paper, 
paper 2, describes aspects of the methodology related to 
SRs in NNR2022. It provides explanations for the step-
wise guidance described in paper 3 (2). The three papers 
should be considered as a unity. 
More than 3 million papers related to diet, food, and/or 
nutrients have been published in different biomedical scien-
tific journals over the last decades. It is impossible for any 
individual to keep track of such a constant and enormous 
production of research results, and studies vary considerably 
in quality and applicability. A single study is often seem-
ingly overturned by later studies (3). With the evolving and 
cumulative nature of scientific knowledge, evidence-based 
practices and guidelines must rely on comprehensive syn-
theses and critical appraisal of the totality of the evidence. 
To prevent the choice of evidence from being subjective and 
skewed (bias), the synthesis should be a systematic, repro-
ducible process, guided by predefined criteria and standards. 
Using SRs (Box 1) to develop dietary guidelines is a 
relatively recent approach, but is increasingly recognized 
as a crucial component (5, 6). As one of the first nutrition 
guidelines, NNR implemented an SR approach in the fifth 
edition, NNR2012. Fifteen de novo SRs were developed as 
part of the NNR2012 project (7). 
According to international standards for guideline de-
velopment, three principles are directly related to SRs (8):
• Systematic methods should be used to search for 
evidence.
• The criteria for selecting the evidence should be clearly 
described.
• The strengths and limitations of the body of evidence 
should be clearly described.
Still, even among dietary guidelines published after 
2010, very few have been based on de novo SRs, although 
some (9–11) did conduct ‘reviews of reviews’, or an um-
brella review that is a synthesis of previously published 
SRs. Very few described methods for identifying the evi-
dence underpinning the guidelines (12).
In addition to the characteristics mentioned in Box 
1, a high-quality SR should take into account: 1) re-
search questions addressing specific populations, in-
terventions/exposures and their comparisons, and 
outcomes; 2) selection and assessment of  eligible stud-
ies by more than one reviewer; 3) use of  appropriate 
statistical methods if  a meta-analysis is performed; 4) 
any heterogeneity across studies; and 5) potential pub-
lication/reporting biases (13).
The process, which has been developed by WHO and 
several other national and international health authori-
ties, can be broadly summarized in five steps (14–19):
1. Formulate research questions and develop a protocol 
including study eligibility criteria.
2. Systematically search, screen, and select studies 
for the review according to prespecified eligibility 
criteria.
3. Extract data from the original studies for analysis, and 
determine risks of bias in individual studies.
4. Synthesize findings and grade the overall quality/
strength of the body of evidence.
5. Make conclusions and report according to reporting 
guidelines.
A SR may include a quantitative synthesis of  re-
search results that estimates an average effect size, a 
meta- analysis, but always includes a qualitative synthe-
sis. Summarizing effect estimates from several studies 
yields a more precise estimate. However, the ability of 
SRs to highlight inconsistencies and/or shortcomings 
Box 1. Systematic reviews
A systematic review (SR) approach is used to study the available scientific evidence to allow firm conclusions to be drawn and to minimize influence 
of reporting bias through comprehensive and reproducible literature searches. In SRs, clearly defined literature search strategies are used together 
with clearly defined and described selections and reporting protocols to provide a comprehensive and distilled evidence document for the decision 
makers/working group and to enhance the transparency of the decision-making process (4). 
The key characteristics of the SR include: 
• A clearly stated set of objectives and research questions with predefined eligibility criteria for the studies (including the outcomes of interest) 
• An explicit, reproducible methodology 
• A systematic search that attempts to identify all studies that would meet the eligibility criteria 
• An assessment of the validity of the findings of the included studies through an assessment of risk of bias of the studies 
• A systematic presentation and synthesis of the characteristics and findings of the included studies 
• A grading of the overall evidence 
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in the body of  evidence, as well as its applicability, is 
just as important for informing decision-makers and 
recommendations. 
Such an approach seeks to curb subjective biases in the 
selection and evaluation of evidence (although it will likely 
not be completely eliminated), which in turn strengthens 
the reliability of the conclusions. 
The conclusion of the SRs is not the same as the final 
recommendations, which are based on several consider-
ations (20). As described in the companion paper (1), there 
are a number of methodological aspects that uniquely 
complicate nutrition research. These also have impli-
cations for synthesizing and interpreting the nutrition 
research literature (5, 21–25). Some important specific 
considerations include the study populations’ nutritional 
status and background diet; the validity of dietary assess-
ment methods; the bioavailability of nutrients and other 
food substances; biological interactions of food compo-
nents; and the many known and unknown factors that 
may confound or mediate relationships between foods/
diets and health outcomes. Comprehensive knowledge of 
such elements is crucial in the interpretation of nutrition 
research, in judging the strength of evidence, and finally 
deriving recommendations.
Development of guidance for SRs
For NNR2012, a SR methodology was developed 
based  on guidance from the Cochrane Collaboration, 
the US Agency for Healthcare Research and Quality 
(AHRQ), and other organizations. With more than 
8,000 SRs published yearly (26), SR as a method is an 
evolving field (27). Thus, the SR methodology devel-
oped for NNR2012 has been updated in the NNR2022 
project. Some important contributions to this update 
include the revised edition of  the Cochrane Collabo-
ration’s Handbook for Systematic Reviews of Interven-
tions and recent updates of  AHRQ’s method guides. 
The Institute of  Medicine (IoM) in the United States 
published the first general standards for SRs in 2011 
(14). More recently, there have also been requests for 
a global harmonization of  SR methods specifically re-
garding nutrition recommendations (28).
The methodology for conducting SRs for NNR2022 
is thus primarily based on state-of-the-art recommen-
dations from AHRQ, Cochrane, and IoM, as these are 
widely used and have a clear theoretical and empirical 
foundation. Recent principles for dietary reference in-
takes developed by the National Academies of Science 
and Medicine (NASEM), the COSMOS-E: Guidance on 
conducting SRs and meta-analyses of observational stud-
ies of etiology (29), and the Preferred Reporting Items 
for SRs and Meta-Analyses (PRISMA), the Meta-analy-
sis of Observational Studies in Epidemiology (MOOSE) 
and AMSTAR standards for reporting of SRs, were also 
incorporated. Methods used for SRs in dietary guidelines 
from other nations and agencies (including USA/Canada, 
World Cancer Research Fund [WCRF], European Food 
Safety Authority [EFSA], Australia) were also assessed.
We found that the previous SR methodology guidance 
for NNR2012 was broadly compatible with more current 
standards, but a few major changes were needed. Some 
changes or refinements were made regarding the develop-
ing of review questions and protocols, search strategies, 
and the assessment of risk of bias.
The aim of this paper is to describe the basic struc-
ture of the SRs conducted in the field of medical and 
nutritional sciences, and the rationale underlying each 
methodological step. The detailed methodology for SRs 
performed as part of the NNR2022 project is described in 
Arnesen et al. (2).
Organization
The SRs for NNR2022 will be conducted by the NNR-SR 
Centre consisting of a multidisciplinary group of scien-
tists, at least one statistician and two research librarians. 
The NNR-SR Centre will be appointed by the NNR 2022 
Committee following an open call for experts and a review 
of their expertise and conflict of interests. 
The tasks of the NNR-SR Centre are to develop liter-
ature search strategies; search, screen, and select eligible 
publications for the review; extract data from publica-
tions and construct evidence tables; qualitatively and/or 
quantitatively analyze the evidence; grade the strength 
of evidence; and write and publish SR reports. The re-
view analysts themselves will not lead the protocol de-
velopment or eligibility criteria; this will be done by the 
NNR2022 Committee. 
Identifying and defining research questions and 
analytic frameworks
A well-formulated review question (or research ques-
tion) is the backbone of  every SR. Usually, several 
questions are developed. They must be clear and un-
ambiguous and are often stated in a structured format 
specifying the population, intervention (or exposure), 
comparator, outcome(s) of  interest, timing, setting, 
and study design (PI/ECOTSS) (Table 1). Not all ques-
tions need to include all of  these elements, but they will 
guide the whole process. 
An analytic (logical) framework is also useful when de-
veloping the review topic and defining eligibility criteria 
(31). This is an overview of the project and the research 
question(s), including PI/ECOTSS elements, connecting 
the intervention/exposure and outcomes. It defines the 
PI/ECOTSS elements more thoroughly, and illustrates 
the causal pathways and potential confounding factors 
to account for. The NNR2022 Committee is responsible 
for developing analytic frameworks. SR questions will 
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be developed in collaboration between the Committee, 
the Scientific Advisory Group, and the NNR-SR Centre. 
Lists of research questions are reported in the protocols 
(see below) and SR papers.
The PI/ECOTSS form the criteria for including or ex-
cluding studies for the review, the eligibility criteria. Hav-
ing prespecified eligibility criteria is one of the defining 
and essential attributes of SRs, and one of the key fac-
tors separating systematic from narrative reviews. Clear, 
explicit, and predefined eligibility criteria limit the room 
for subjective and biased selection of studies for the re-
view, and make the review more reproducible (29). Spe-
cifically, criteria for types of participants, interventions/
exposures, and comparators (for controlled intervention 
studies), design and time frames, are defined and stated in 
the protocols. Any changes in eligibility criteria during the 
search process will be documented in the reviews. How-
ever, eligibility criteria will not be changed on the basis 
of the results.
As the focus of NNR on prevention, studies including 
only a particular patient group or institutionalized peo-
ple will often be excluded. Studies including both healthy 
populations and people with elevated risk of chronic dis-
ease or established chronic disease, including obesity, hy-
percholesterolemia, and hypertension, may be included if  
deemed appropriate. For intervention studies, criteria for 
dose level, duration, mode of administration, and so on 
are also defined.
Eligible study designs are randomized or nonrandom-
ized controlled trials (intervention studies), or obser-
vational prospective cohort studies, case-cohort and/or 
case-control studies. Cross-sectional studies, uncontrolled 
trials, case reports, and reviews will be excluded. Studies 
lacking any measure of intake of the foods or nutrients 
of interest, and studies with multicomponent intervention 
where the effect of dietary variables cannot be assessed 
independently, will be excluded. 
Eligibility criteria 
For intervention studies, the following criteria are in gen-
eral predefined. For each specific SR, the criteria may be 
altered due to certain circumstance. In such cases, it will 
clearly be stated and the reason for changing the criteria 
will be described.
• Minimum duration. Should be at least 4 weeks, specific 
criteria should be defined depending on type of out-
come (e.g. risk factor or disease endpoint).
For observational studies, the following criteria are defined:
• Minimum follow-up period. At least 6 months, could 
be shorter depending on outcome.
For all the study types, the intake ranges for nutrients 
and dietary sources should be relevant to the Nordic 
population.
Protocols
Protocols will be preregistered by the NNR-SR Centre in 
the PROSPERO (Prospective Register of Ongoing SRs) 
database (http://www.crd.york.ac.uk/prospero). In re-
porting the SRs, authors will follow the latest versions of 
the PRISMA and MOOSE reporting guidelines.
Literature search
A transparent literature search strategy is one of the 
major differences between a systematic and a non-system-
atic (‘narrative’) review. This is essential for minimizing 
bias in the study selection and for drawing reliable con-
clusions. There is little direct evidence for how each step 
in the search process affects the results of the SR, but not 
performing a comprehensive, systematic search comes 
with large risk (14).
Searching for relevant evidence involves finding a 
balance between sensitivity and specificity. The broader 
Table 1. Example of research questions based on the PI/ECOTSS elements (30)
PI/ECOTSS Example
Population Demographics, health status, and so on in the populations receiving an  
intervention or exposure
Adults
Intervention/exposure Type of intervention, dosage or level of intake, delivery Dietary macronutrient composition
Comparator Placebo/control group, alternative exposure, or other level of exposure Alternate macronutrient composition
Outcome Health outcome, surrogate outcome, mortality Body weight, body fat and/ 
or waist circumference (WC)
Timing Duration of intervention or follow-up ³1-year follow-up
Setting Background context, co-intervention, healthcare, and so on Free-living
Study design Randomized controlled trial Randomized controlled trials
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(i.e. sensitive) the search strategy, the more evidence will 
be identified, at the expense of retrieving many non-rele-
vant data as well. The search strategies for the NNR2022 
reviews will aim for high sensitivity, using validated search 
filters by Cochrane and the Scottish Intercollegiate Guide-
lines Network (www.sign.ac.uk).
Search strategies will be developed for each review 
question by research librarians or other experts in SRs, in 
collaboration with the NNR2022 Committee, and build 
on the PI/ECOTSS components.
Databases searched always include Medline/PubMed 
and the Cochrane Library’s CENTRAL register of con-
trolled trials. Review authors may also search Embase 
and/or specialized databases if  necessary for the given 
topic. Reference lists in the included papers and other rel-
evant SRs will also be examined. In addition, cited refer-
ence searches – to find newer papers citing the included 
papers – will be performed with, for example, Web of 
Science, Scopus, Google Scholar, and so on. Any errata 
and letters concerning the papers are also examined. The 
search strategies will be peer reviewed by a research librar-
ian or an expert in SRs outside the review team before the 
formal search process starts.
Searching for ‘gray literature’, that is, publications 
outside peer-review journals, such as study protocols, 
conference abstracts, or government reports, will not 
be mandatory. Observational studies, which likely will 
make up a large part of  the literature, are rarely pre-
registered and often do not have a protocol, so the 
likelihood of  finding unpublished studies by searching 
registries is uncertain (32). Authors of  retrieved papers 
may be contacted for non-reported data or to clarify 
issues.
No restriction on publication language or date will be 
included in the search strategy. Both text-word terms and 
medical subject headings/controlled vocabulary/indexing 
terms (e.g. MeSH in Medline) will be used.
The methods section in each SR documents the da-
tabases and any other sources searched, search dates, 
and any restrictions. Searches will be updated within 12 
months before publication, and then screened for poten-
tially new eligible studies. Dates of the most recent da-
tabase search are reported in each chapter. Full search 
strategies will be included as supplementary material ac-
companying each report.
Screening and selection of eligible studies
All citations found are screened applying the prespecified 
eligibility criteria (see above).
This will first be pilot tested with two reviewers inde-
pendently screening 10% of the titles and abstracts. This will 
assess the clarity and understanding of the eligibility criteria 
and the search strategy. If good agreement is not achieved, 
the eligibility criteria will be refined or clarified (2).
At least two or more reviewers will then perform the 
screening independently. In the screening phase, any dis-
agreements between the screeners will be discussed with 
a third reviewer to define the discrepancies and make a 
collaborative decision. First, titles and abstracts of all 
initially retrieved citations are screened, before full-text 
publications of those identified as potentially relevant are 
assessed (Fig. 1).
In the first screening phase, obviously irrelevant articles 
(based on titles and/or abstracts) will be excluded. If  the 
relevance is uncertain, the article is forwarded to the next 
step (i.e. an ‘over-inclusive’ approach is used (34)). No 
data collection or quality assessment will be performed 
up to this point. If  necessary, study authors will be con-
tacted for missing data or other information to clarify el-
igibility. Masking of study authors, results, and so on will 
not be performed during the selection process. Citations 
excluded after full-text assessments will be documented 
along with reasons for exclusion, and reported in flow dia-
grams, following the PRISMA standards. Again, reasons 
for any discrepancies between the reviewers will be dis-
cussed and addressed, with inputs from another member 
of the review team until consensus is achieved. 
One study often has multiple reports that can be rele-
vant for the topic. If  one study is analyzed in more than 
one paper, those papers will be linked such that the study 
itself  is the unit. 
Data extraction 
The extraction tables developed in this stage will facil-
itate the later assessment of  risk of  bias and data syn-
thesis. Qualitative and quantitative data will be collected 
Fig. 1. Screening process. Partly adapted from EFSA (19) 
and Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) (33).
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from each eligible publication and registered in detailed, 
predefined extraction forms developed for each review. 
The extraction forms generally include data on source 
(full reference), eligibility, methodology (e.g. study de-
sign, duration/follow-up time, randomization details, 
blinding), participants and settings, interventions/ex-
posures, endpoints, results (unadjusted and adjusted 
estimates, except for adjustment models containing 
variables in the causal pathway), confounding variables 
and effect modifiers, study sponsor, study author’s con-
clusions, and reviewers’ comments. Nutrition-specific el-
ements, such as intake levels/dose, food source, method 
for dietary assessment, validation of  dietary assessment 
method, food composition database used, and assess-
ment of  nutrition status, are given a special emphasis (5), 
and STROBE-NUT guidelines are applied in designing 
the standardized data extraction form for dietary infor-
mation (22). As different dietary assessment methods 
suffer from specific measurement errors, a careful assess-
ment of  the method used is essential to allow correct in-
terpretation of  the findings. 
Data extractions forms will be pretested within the 
NNR-SR Centre with a handful of included papers to 
check their feasibility and comprehensibility. The data to 
be collected, and a procedure to extract the data, will be 
predetermined by the reviewers, but as for the selection 
process, data will be extracted by at least two reviewers in-
dependently. This is a method for limiting recording errors, 
which may be large, regardless of the extractors’ experience 
(35). It is especially important to have two or more persons 
extracting endpoint data. Again, study authors will be con-
tacted, if necessary, about missing or unclear data. 
Assessment of risk of bias 
Before summarizing the research and form conclusions, 
it is necessary to assess the validity of, or the confidence 
in, the available evidence. An assessment of  risk of 
bias of  the included studies is an important difference 
between SRs and narrative reviews. This is also a pre-
requisite for evaluating the overall strength of  evidence 
(see below). Even if  the results are consistent across all 
studies, the conclusions are not sound if  the studies are 
flawed and biased. Importantly, each study must be crit-
ically appraised on their own, not simply based on their 
assigned design labels (such as ‘randomized controlled 
trials’ [RCTs]) (36). 
Study quality is a broad concept that includes measure-
ment methods, precision, potential for random errors, 
applicability, and quality of the reporting (14). Whether 
the study has a sound research question according to the 
objectives, and its generalizability, are indicators of exter-
nal validity.
Risk of bias is another quality aspect, concerning the 
study’s internal validity. Internal validity refers to whether 
the study ‘correctly’ answers the research question (29, 
37). This affects one’s confidence in the causal effect of the 
intervention. Compared with the other quality measures, 
the risk of bias concerns what actually happened in the 
study, not just how it was designed. A study may be well 
designed, but still have a high risk of bias.
The Cochrane Collaboration defines bias as ‘systematic 
error, or deviations from the truth, in results or interpre-
tation’, which leads to over- or underestimating the true 
intervention effect (37). This should not be confused with 
lack of precision, which leads to random errors that can 
cancel out each other with sufficient replication. Criteria 
for determining risk of bias in an individual study should 
be separated from criteria for judging precision, direct-
ness, and applicability (36). 
Causes of bias are mainly related to the randomization 
process (in RCTs), deviations from intended interventions, 
missing outcome data, measurement of the outcome, and 
selection in the reported result (38). These domains have 
also been named selection bias, performance bias, attri-
tion bias, detection bias, and reporting bias (see Table 2) 
(37, 38). 
Risk of bias assessment is more complicated with non-
randomized studies, such as prospective cohort studies 
(32). However, selection bias, performance bias, detection 
bias, attrition bias, and reporting bias should be assessed 
(2). Especially, the potential for selection bias is likely 
higher in most nonrandomized studies, such that the ex-
posed and non-exposed groups are imbalanced when it 
comes to prognostic factors. It is important to identify 
these confounding factors and to assess how they were 
managed.
In observational studies, misclassification (or infor-
mation/recall) bias may also occur (39), that is, bias due 
to how the exposure was defined and assessed. There is 
empirical evidence that several of these risk-of-bias-do-
mains may exaggerate effects of interventions (26, 40). In 
nutrition, the issue of exposure assessment is especially 
important to consider when deriving recommendations 
based on intake-response associations (6, 22, 41).
Handling of risk of bias in the NNR2022 SRs
The assessment of risk of bias will be planned and de-
scribed in protocols for each review, where the specific 
endpoints for which risk of bias assessments to be per-
formed are stated. Risk of bias will be assessed for at least 
one specific key endpoint for each study by at least two 
independent reviewers. If  disagreements are not resolved 
by the two reviewers, a third reviewer will be involved. To 
reduce subjective judgments, the risk of bias assessors are 
provided with definitions of the domains (i.e. randomiza-
tion, blinding, attrition, and so on). The response options 
are ‘Yes/Probably yes’, ‘No/Probably no’, or ‘No informa-
tion’ (35, 36). 
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A study may have low, some, or high risk for bias within 
each domain. The overall risk of bias per study is also 
judged as low, high, or some concerns. If  there is a high 
risk of bias in one of the mentioned domains, the study 
is judged to be at high risk of bias overall. A ‘low’ risk 
of bias judgment does not require that the study is to-
tally free from any type of bias, but that the bias is not so 
serious that it has any appreciable bearing on the results 
or conclusions. For instance, blinding is usually not pos-
sible in food-based dietary intervention, but this may not 
always imply a high risk of bias as long as it would not 
have influenced the outcome. Hence, it is important to ac-
knowledge that the judgment of a study’s risk of bias also 
depends on to what extent it is likely to affect the results. 
There is a lack of strong empirical evidence that one 
way of assessing the risk of bias is superior. Hence, many 
different approaches exist (42). The use of quality scales 
(e.g. the often used Jadad scale for trials), in which a sum-
mary, numeric quality score is calculated, may be mislead-
ing, even causing contradictory conclusions about effects, 
and is discouraged (29, 42–45). It has become more com-
mon to use and classify study quality simply as ‘good’, 
‘poor’ or ‘fair’, or similar. 
The risk of bias assessments for de novo SRs in the 
NNR2022 project will be based on Cochrane’s risk of bias 
tool (‘Risk of bias 2.0’) for RCTs (38). For non- randomized 
trials, the assessments will be based on the recent Risk of 
Bias in Non-randomized Studies of Interventions (ROB-
INS-I) instrument, (36, 39) developed by Cochrane col-
laborators. For observational studies (prospective cohort 
studies, case-cohort studies or case-control studies), we 
will use the recently developed ‘Risk of Bias for Nutri-
tion Observational Studies’ (RoB-NObS) tool developed 
by the USDA’s Nutrition Evidence Systematic Review 
(NESR) team (46). For each SR, a table/check list with 
additional questions will be included to add emphasis on 
bias linked to specific nutrient or diet-related issues such 
as misclassification due to selection, comparability be-
tween exposure groups (i.e. confounding), and exposure 
and outcome ascertainment (29, 47).
Data synthesis
After the study data have been extracted and tabulated, 
and the risk of bias of each study has been assessed, the 
information will be integrated to allow an interpretation 
of the overall body of evidence, including its quality. The 
reviewers will qualitatively summarize the findings in sum-
mary-of-findings tables. These tables include the main re-
sults, including continuous endpoint measures (e.g. mean 
differences) or categorical endpoint measures (e.g. relative 
risks or hazard ratios), with 95% confidence intervals. 
Table 3 is an example of summary table headings. 
There are a number of ways in which studies may be 
grouped for presentation. Grouping could be done ac-
cording to study design or other major factors that may 
influence the results. Forest plots of results can be used to 
illustrate results of individual studies.
If  appropriate, meta-analyses will be performed. A 
meta-analysis is a quantitative combination of study 
level (or, in some cases, participant level) data from 
Table 2. Sources of bias (37, 38)
Main type of bias Explanation Issues
Selection bias – bias arising 
from the randomization 
process
Assignment to intervention group is influenced 
by prognostic factors, leading to systematic dif-
ferences in background characteristics between 
the groups being compared (i.e. confounding). 
Randomized, concealed allocation to groups 
uniquely limits selection bias.
- Sequence generation (was the recruitment random?)*
-  Concealed allocation (was the allocation of participants to 
groups concealed and unpredictable for participants and 
investigators?)*
- Control for confounding factors** 
Performance bias – bias due 
to deviations from intended 
interventions
Non-protocol interventions given, failure to im-
plement the protocol, or non-adherence to the 
intervention by participants, due to awareness 
of intervention assignment.
- Blinding of participants and investigators*
-  Effect of assignment to intervention (‘intention to treat’) vs. 
effect of adherence to intervention (‘per protocol’ effect).
Detection bias – bias in  
measurement of the 
outcome
Measurement error or misclassification of 
outcomes. Causes bias if different between the 
groups.
- Measuring methods appropriate?
-  Blinding of outcome assessors
-  Other potential threats to validity, for example, inadequate 
statistical analyses; exposure assessment method
Attrition bias – bias due to 
missing outcome data
Systematic differences in attrition or length 
of follow-up of participants between groups, 
leading to incomplete outcome data.
- Dropout or loss to follow-up
-  Missingness is not by chance, but related to intervention group 
and the value of the outcome
Reporting bias– bias in  
selection of the reported 
result
Systematic differences in what outcome mea-
surement or analysis is reported and not. 
-  Selective endpoint reporting; unfavorable or insignificant findings 
are less likely to be published (are any prespecified or expected 
key outcomes not reported?)
*Not applicable to observational studies.
**Applicable to observational studies. 
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independent studies. Meta-analysis produces an average 
effect estimate, weighted by study precision. Meta-anal-
ysis as a method improves the statistical power to detect 
differences by increasing the total sample size, providing a 
more precise effect estimate. It is also useful for highlight-
ing between-study heterogeneity. 
However, meta-analyses must be carefully interpreted. 
They should not always be performed; if  the included 
studies are highly heterogeneous in terms of study pop-
ulations or settings, interventions and study designs, and/
or have low quality, a statistical combination of the data 
will not give a meaningful answer (48). The meta-anal-
ysis may not estimate one ‘true’ intervention effect, but 
rather a distribution of effects (49). Systematic (i.e. not 
random) errors from different studies are not cancelled 
out when studies are combined in a meta-analysis. Thus, 
when studies show high heterogeneity and/or risk of bias, 
it is generally discouraged to use meta-analysis. Similar to 
other types of evidence syntheses, the validity of meta-an-
alyzed results is also affected by the risk of publication or 
reporting bias – unfavorable or insignificant findings are 
less likely to be published. 
Dose–response effects/relationships will be assessed if  
sufficient data allow. The meta-analyses will assess statis-
tical heterogeneity between studies, which will be further 
explored by sensitivity analyses. In the case of consider-
able inconsistency in results, for example, an I2 statistic 
of 75–100% (49), the effect estimates will not be pooled 
statistically. Sources of heterogeneity to be explored in-
clude PI/ECOTSS elements and risk of bias domains. 
Any sensitivity or subgroup analyses will be prespeci-
fied in the protocols of each review. When the risk of 
bias varies across studies, the primary meta-analyses are 
restricted to those with low risk of bias, and sensitivity 
analyses are performed to compare effects according to 
study quality (50). If  10 or more studies are included in 
the meta-analysis, tests for publication bias will be per-
formed. Meta-analyses will be performed separately with 
interventional and observational studies. 
Assessment of the strength of evidence
In the context of SRs, the strength of evidence, or the 
quality of the body of evidence, refers to the extent one 
can be confident that the effect estimate across the stud-
ies is true (14, 16, 51). The degree of confidence depends 
broadly speaking on the quality, quantity, and consistency 
of the evidence base (52, 53).
There is no empirical evidence or agreement on one par-
ticular method or terminology for evaluating and describ-
ing the quality of the totality of evidence. There are many 
different systems; a 2005 study identified more than 50 
different systems for grading the evidence, and 230 instru-
ments for assessing study quality (14). The most common 
approach is the Grading of Recommendations, Assessment, 
Development, and Evaluation (GRADE) methodology in 
which the evidence is categorized as high, moderate, low, 
and very low quality. Nevertheless, the basic consider-
ations in most evidence quality assessments are: 
1. risk of bias (study limitations) 
2. consistency of the results (i.e. the relative effect 
measures) 
3. precision (width of the 95% confidence interval around 
the effect estimate) 
4. directness (including external validity) 
5. reporting bias (only for RCTs) and, for observational 
studies, also: 
6. dose–response relationship 
7. plausible confounding that would have changed the re-
ported effect 
8. strength of the association (16, 25, 51). 
Evaluation of the strength of evidence for a causal re-
lationship between a food group or a nutrient exposure 
and a health-related outcome is not trivial. In addition 
to the many general scientific issues in medical sciences, 
there are several specific challenges of human nutrition re-
search. The assessment of causality in nutritional studies, 
and their implication for NNR2022, will be discussed in a 
forthcoming paper.
Strength of evidence
In general, the body of  evidence for the most relevant 
outcomes will be evaluated based on all the factors in 
the GRADE methodology. The approach for grading 
developed by the WCRF/AICR (23) will be used to de-
scribe the strength of  evidence. This incorporates the 
quality and quantity of  the totality of  the evidence, 
unexplained heterogeneity in results, the presence of 
a dose–response relationship, and biological plausi-
bility. This was also used in NNR2012 and previous 
food-based dietary guideline (FBDG) developments in 
Norway and Denmark, and in the Global Burden of 
Disease study (50) 
Table 3. Example of a summary table
Exposure/intervention No. of participants/no. of studies Outcome variable Relative risk (RR)  
(95% confidence interval [CI])
Effect Risk of bias Comments
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The grading of the evidence for causal relationships, for 
both reduction and increase in risk, results in one of the 
following grading categories (Table 4): 
- convincing 
- probable 
- limited –suggestive 
- limited – no conclusion
- substantial effect unlikely 
Grading of ‘convincing’ or ‘probable’ is generally consid-
ered as strong enough evidence for informing dietary ref-
erence values (DRVs) and FBDGs (1).
Mendelian randomization (MR) studies may also give 
support for causal interpretations of observational asso-
ciation, being less affected by confounding and bias than 
traditional observational studies (1). MR studies have 
contributed to the establishment of biomarkers such as 
low-density lipoprotein (LDL)-cholesterol, triglycerides, 
and blood pressure as causal risk factors for cardiovascu-
lar disease, which also have implications for the strength 
of evidence of nutrition recommendations. Dietary in-
terventions that report sufficiently large changes in such 
causal risk factors may then be considered clinically rel-
evant and may be more confidently extrapolated to hard 
endpoints. 
In GRADE, RCTs without substantial weaknesses 
are judged as high-quality evidence, while observa-
tional studies a priori start with a low-quality grading 
(but may be upgraded). However, judging RCTs auto-
matically as ‘high-quality’ evidence may be misleading 
with nutritional interventions due to inherent method-
ological challenges (6, 54, 55). With the exception of 
this, the aspects for strength-of-evidence considered 
by WCRF’s and GRADE’s tools are largely similar in 
concept. For comparison, GRADE ranks the evidence 
quality, as shown in Table 5.
With observational evidence, GRADE upgrades the 
strength of evidence with 1 point if  the relative risk (RR) 
is >2 or <0.5, and with 2 points if  RR >5 or <0.2. It is 
also upgraded by 1 point if  there is a dose–response rela-
tionship and if  any confounding factors would have un-
derestimated the observed effect.
Two reviewers will independently assess each do-
main and grade the total strength of evidence accord-
ing to the WCRF criteria in the NNR2022 project. Any 
Table 4. The World Cancer Research Fund (WCRF) categorization of strength of evidence
Evidence of causality Strength of evidence Explanation
Convincing Strong evidence The evidence is strong enough to judge an association between the exposure and outcome as 
convincing, and to make a recommendation for reducing risk. This is unlikely to be changed in 
the light of more studies. 
Probable The evidence is strong enough to support a causal relationship as probable, justifying a recom-
mendation for reducing risk.
Substantial effect on  
risk unlikely
The evidence is strong enough to support a judgment that there is no substantial causal asso-
ciation between the exposure and the outcome. This is unlikely to be changed in the light of 
more studies. 
Limited – suggestive Weak evidence The evidence is too limited to conclude for a probable or convincing causal association but 
suggests direction of an effect. There may be methodological flaws or few studies, but they show 
a generally consistent direction. The evidence is rarely sufficient to warrant recommendations. 
Limited – no conclusions Insufficient evidence The evidence is too limited to make a conclusion. There may be too few studies, too inconsistent 
directions of effects, or a combination. Most studies have poor quality, or two or more high-qual-
ity studies have opposite or negative results. Further research might give evidence for or against 
a causal relationship with more certainty.
Table 5. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) categorization of strength of evidence
Quality grade Definition
High We are very confident that the true effect lies close to that of the estimate of the effect.
Moderate We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a 
possibility that it is substantially different.
Low Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.
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disagreement will be solved in a consensus process with 
the whole group of reviewers.
Conclusion
SRs will be a major fundament in developing nutrient 
recommendations or FBDGs in the NNR2022 project. 
This paper substantiates the specific, stepwise recom-
mendations and expectations of SRs for NNR2022. The 
methodology for SRs in NNR2022 is informed by current 
advances in guideline development and SR standards. It 
could be adapted for use by other countries or organiza-
tions formulating nutrient recommendations or FBDGs. 
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See sections on “Conflicts of interest” and “Sponsors of 
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